Medscape Medical NewsAll articles

Belun Sleep System BLS-100

Belun Technology Company Limited • Anesthesiology • 02/23/2023

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

The Belun Sleep System BLS-100 is a home-use wearable device designed to aid in the evaluation of moderate to severe sleep-related breathing disorders by continuously monitoring physiological parameters such as SpO2, pulse rate, and movement via a finger-worn ring. Its accompanying AI software analyzes this photoplethysmography and actigraphy data to generate an apnea-hypopnea index and identify sleep stages, offering a non-invasive alternative to traditional polysomnography for adult patients.

Summary

The Belun Sleep System BLS-100, by Belun Technology Company Limited, is a prescription-based wearable device for adult patients to conduct home sleep apnea tests, aiding healthcare professionals in evaluating moderate to severe sleep-related breathing disorders like Obstructive Sleep Apnea (OSA). The system features the Belun Ring (models BLR-100X for continuous up to 10-hour monitoring or BLR-100C for spot-checking), worn on the proximal phalanx of the index finger. This ring employs red and infrared LEDs for photoplethysmography (PPG) to measure arterial hemoglobin oxygen saturation (SpO2) and pulse rate, while an integrated accelerometer tracks movement (actigraphy) and records beat-to-beat pulse period. Data collection, which occurs during both motion and no-motion conditions, is stored on the ring (e.g., BLR-100X holds up to 10 hours) and can be exported via USB or Bluetooth to the stand-alone Belun Sleep AI software on a personal computer; the device does not feature alarms. The Belun Sleep AI software utilizes machine learning algorithms to analyze the collected physiological data, generating an apnea-hypopnea index (bAHI) and identifying sleep stages (bSTAGES: wake, NREM, and REM). The system's efficacy was evaluated in a clinical study with 106 patients, comparing its AHI and sleep staging capabilities against polysomnography (PSG), which yielded an AHI accuracy of 0.877 at a 15 events/hour cutoff and 0.925 at a 30 events/hour cutoff, alongside reported accuracies for sleep stage categorization. The Belun Sleep System BLS-100 has undergone extensive non-clinical testing, confirming compliance with numerous international standards for safety (IEC 60601 series), performance (ISO 80601-2-61), biocompatibility (ISO 10993 series for skin-contacting materials), and usability for hospital and home environments, with cleaning performed using 70% isopropyl alcohol.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Sleep ApneaBelun Sleep System BLS-100Photoplethysmography (PPG)SpO2Pulse RateActigraphyApnea-Hypopnea Index (bAHI)Sleep Staging (bSTAGES)Wearable SensorHome Sleep Test

Device Metadata

Submission Number
K222579
Company
Belun Technology Company Limited
Panel
Anesthesiology
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
diagnosis

Relevant Clinical Questions

  • Q1. How does the Belun Sleep AI algorithm differentiate between central and obstructive apnea events, or does it primarily focus on the overall AHI?; What are the specific sensitivity and specificity values for detecting REM and NREM sleep stages compared to PSG, beyond general accuracy statements?; How does the device's performance vary across different patient populations (e.g., varying skin tones, peripheral vascular disease, or high BMI) that might affect PPG signal quality?; What is the typical battery life of the Belun Ring during continuous 10-hour recording, and how does it degrade over the device's lifespan?; Given the stand-alone software, what are the cybersecurity measures implemented beyond data encryption during export to protect patient data stored on the local PC?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score60/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(remote, bluetooth)
✓ Detected
HBOMHardware Bill of Materials(sensor)
✓ Detected
CBOMCryptography Bill of Materials(encryption)
✓ Detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, HBOM, CBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Not detected in AI-generated device summary: SBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Belun Sleep System BLS-100 - Belun Technology Company Limited | ESL FDA AI Device Intelligence